Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Receptivity of Endometrial Tissue and Peripheral Blood Mononuclear Cells in the Pathogenetic Rationale for the Management of Postmenopause Patients With Endometrial Proliferative Processes

NCT06115577 is registered in ClinicalTrials.gov with Pirogov Russian National Research Medical University as lead sponsor.

NCT NCT06115577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06115577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Receptivity of Endometrial Tissue and Peripheral Blood Mononuclear Cells in the Pathogenetic Rationale for the Management of Postmenopause Patients With Endometrial Proliferative Processes
Lead sponsor
Pirogov Russian National Research Medical University
Phase
Observational
Overall status
Completed
Start date
October 1, 2012
Completion date
August 1, 2022
Enrollment
92 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, endometrial hyperplasia with atypia, endometrial hyperplasia without atypia, estrogen receptor, peripheral blood mononuclear cells, postmenopause, progesterone receptor